Влияние эндогенного тестостерона на здоровье и качество жизни у женщин в постменопаузе

1. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018; 392(10159): 1684-735. https://dx.doi.org/10.1016/S0140-6736(18)31891-9
2. United Nations, Department of Economic and Social Affairs, Population Division. World Population Prospects 2019. https://www.un.org/development/desa/pd/news/world-population-prospects-2019-0
3. Stramba-Badiale M., Fox K.M., Priori S.G., Collins P., Daly C., Graham I. et al. Cardiovascular diseases in women: a statement from the policy conference of the European Society of Cardiology. Eur. Heart J. 2006; 27(8): 994-1005. https://dx.doi.org/10.1093/eurheartj/ehi819
4. Kontis V., Bennett J.E., Mathers C.D., Li G., Foreman K., Ezzati M. Future life expectancy in 35 industrialised countries: projections with a Bayesian model ensemble. Lancet. 2017; 389(10076): 1323-35. https://dx.doi.org/10.1016/S0140-6736(16)32381-9
5. Davis S.R., Panjari M., Stanczyk F.Z. DHEA replacement for postmenopausal women. J. Clin. Endocrinol. Metab. 2011; 96(6): 1642-53. https://dx.doi.org/10.1210/jc.2010-2888
6. Labrie F., Martel C., Bélanger A., Pelletier G. Androgens in women are essentially made from DHEA in each peripheral tissue according to intracrinology. J. Steroid Biochem. Mol. Biol. 2017; 168: 9-18. https://dx.doi.org/10.1016/j.jsbmb.2016.12.007
7. Labrie F. Intracrinology and menopause: the science describing the cell-specific intracellular formation of estrogens and androgens from DHEA and their strictly local action and inactivation in peripheral tissues. Menopause. 2019; 26(2):220-4. https://dx.doi.org/10.1097/GME.0000000000001177
8. Goldman A.L., Bhasin S., Wu F.C.W., Krishna M., Matsumoto A.M., Jasuja R. A reappraisal of testosterone's binding in circulation: physiological and clinical implications. Endocr. Rev. 2017; 38(4): 302-24. https://dx.doi.org/10.1210/er.2017-00025
9. Handelsman D.J. Free testosterone: pumping up the tires or ending the free ride? Endocr. Rev. 2017; 38(4): 297-301. https://dx.doi.org/10.1210/er.2017-00171
10. Davis S.R., Baber R., Panay N., Bitzer J., Cerdas Perez S., Islam R.M. et al. Global Consensus Position Statement on the use of testosterone therapy for women. Climacteric. 2019; 22(5): 429-34. https://dx.doi.org/10.1080/13697137.2019.1637079
11. Davis S.R., Bell R.J., Robinson P.J., Handelsman D.J., Gilbert T., Phung J. et al.; ASPREE Investigator Group. Testosterone and estrone increase from the age of 70 years: findings from the sex hormones in older women study. J. Clin. Endocrinol. Metab. 2019; 104(12): 6291-300. https://dx.doi.org/10.1210/jc.2019-00743
12. Cappola A.R., Ratcliffe S.J., Bhasin S., Blackman M.R., Cauley J., Robbins J. et al. Determinants of serum total and free testosterone levels in women over the age of 65 years. J. Clin. Endocrinol. Metab. 2007; 92(2): 509-16. https://dx.doi.org/10.1210/jc.2006-1399
13. Aribas E., Roeters van Lennep J.E., De Rijke Y.B., Laven J.S.E., Ikram M.A., Peeters R.P. et al. Sex steroids and sex steroid-binding globulin levels amongst middle-aged and elderly men and women from general population. Eur. J. Clin. Invest. 2022; 52(12): e13866. https://dx.doi.org/10.1111/eci.13866
14. Skiba M.A., Bell R.J., Islam R.M., Handelsman D.J., Desai R., Davis S.R. Androgens during the reproductive years: what is normal for women? J. Clin. Endocrinol. Metab. 2019; 104(11): 5382-92. https://dx.doi.org/10.1210/jc.2019-01357
15. Patel S.M., Ratcliffe S.J., Reilly M.P., Weinstein R., Bhasin S., Blackman M.R. et al. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease. J. Clin. Endocrinol. Metab. 2009; 94(12): 4776-84. https://dx.doi.org/10.1210/jc.2009-0740
16. Biegelsen E., Loscalzo J. Endothelial function and atherosclerosis. Coron. Artery Dis. 1999; 10(4): 241-56.
17. Campelo A.E., Cutini P.H., Massheimer V.L. Cellular actions of testosterone in vascular cells: mechanism independent of aromatization to estradiol. Steroids. 2012; 77(11): 1033-40. https://dx.doi.org/10.1016/j.steroids.2012.05.008
18. Grohé C., Kahlert S., Löbbert K., Vetter H. Expression of oestrogen receptor alpha and beta in rat heart: role of local oestrogen synthesis. J. Endocrinol. 1998; 156(2): R1-7. https://dx.doi.org/10.1677/joe.0.156r001
19. Bell J.R., Mellor K.M., Wollermann A.C., Ip W.T., Reichelt M.E., Meachem S.J. et al. Aromatase deficiency confers paradoxical postischemic cardioprotection. Endocrinology. 2011; 152(12): 4937-47. https://dx.doi.org/10.1210/en.2011-1212
20. Montalcini T., Gorgone G., Gazzaruso C., Sesti G., Perticone F., Pujia A. Endogenous testosterone and endothelial function in postmenopausal women. Coron. Artery Dis. 2007; 18(1): 9-13. https://dx.doi.org/10.1097/01.mca.0000236290.79306.d1
21. Rech C.M., Clapauch R., de Souza Md., Bouskela E. Low testosterone levels are associated with endothelial dysfunction in oophorectomized early postmenopausal women. Eur. J. Endocrinol. 2016; 174(3): 297-306. https://dx.doi.org/10.1530/EJE-15-0878
22. Nie G., Yang X., Wang Y., Liang W., Li X., Luo Q. et al. The effects of menopause hormone therapy on lipid profile in postmenopausal women: a systematic review and meta-analysis. Front. Pharmacol. 2022; 13: 850815. https://dx.doi.org/10.3389/fphar.2022.850815
23. Kische H., Gross S., Wallaschofski H., Völzke H., Dörr M., Nauck M. et al. Clinical correlates of sex hormones in women: The study of health in Pomerania. Metabolism. 2016; 65(9): 1286-96. https://dx.doi.org/10.1016/j.metabol.2016.05.011
24. Bell R.J., Davison S.L., Papalia M.A., McKenzie D.P., Davis S.R. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span. Menopause. 2007; 14(4): 630-8. https://dx.doi.org/10.1097/GME.0b013e31802b6cb1
25. Worsley R., Robinson P.J., Bell R.J., Moufarege A., Davis S.R. Endogenous estrogen and androgen levels are not independent predictors of lipid levels in postmenopausal women. Menopause. 2013; 20(6): 640-5. https://dx.doi.org/10.1097/GME.0b013e318279bd4a
26. Davis S.R., Robinson P.J., Moufarege A., Bell R.J. The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women. Clin. Endocrinol. (Oxf). 2012; 77(4): 541-7. https://dx.doi.org/10.1111/j.1365-2265.2011.04301.x
27. Muka T., Nano J., Jaspers L., Meun C., Bramer W.M., Hofman A. et al. Associations of steroid sex hormones and sex hormone-binding globulin with the risk of type 2 diabetes in women: a population-based cohort study and meta-analysis. Diabetes. 2017; 66(3): 577-86. https://dx.doi.org/10.2337/db16-0473
28. Benn M., Voss S.S., Holmegard H.N., Jensen G.B., Tybjærg-Hansen A., Nordestgaard B.G. Extreme concentrations of endogenous sex hormones, ischemic heart disease, and death in women. Arterioscler. Thromb. Vasc. Biol. 2015; 35(2): 471-7. https://dx.doi.org/10.1161/ATVBAHA.114.304821
29. Laughlin G.A., Goodell V., Barrett-Connor E. Extremes of endogenous testosterone are associated with increased risk of incident coronary events in older women. J. Clin. Endocrinol. Metab. 2010; 95(2): 740-7. https://dx.doi.org/10.1210/jc.2009-1693
30. Schaffrath G., Kische H., Gross S., Wallaschofski H., Völzke H., Dörr M. et al. Association of sex hormones with incident 10-year cardiovascular disease and mortality in women. Maturitas. 2015; 82(4): 424-30. https://dx.doi.org/10.1016/j.maturitas.2015.08.009
31. Schederecker F., Cecil A., Prehn C., Nano J., Koenig W., Adamski J. et al. Sex hormone-binding globulin, androgens and mortality: the KORA-F4 cohort study. Endocr. Connect. 2020; 9(4): 326-36. https://dx.doi.org/10.1530/EC-20-0080
32. Sievers C., Klotsche J., Pieper L., Schneider H.J., März W., Wittchen H.U. et al. Low testosterone levels predict all-cause mortality and cardiovascular events in women: a prospective cohort study in German primary care patients. Eur. J. Endocrinol. 2010; 163(4): 699-708. https://dx.doi.org/10.1530/EJE-10-0307
33. Islam R.M., Bell R.J., Handelsman D.J., McNeil J.J., Nelson M.R., Reid C.M. et al. Associations between blood sex steroid concentrations and risk of major adverse cardiovascular events in healthy older women in Australia: a prospective cohort substudy of the ASPREE trial. Lancet Healthy Longev. 2022; 3(2): e109-e118. https://dx.doi.org/10.1016/S2666-7568(22)00001-0
34. Davis S.R., Azene Z.N., Tonkin A.M., Woods R.L., McNeil J.J., Islam R.M. Higher testosterone is associated with higher HDL-cholesterol and lower triglyceride concentrations in older women: an observational study. Climacteric. 2024; 27(3): 282-8. https://dx.doi.org/10.1080/13697137.2024.2310530
35. Kendler D.L., Bauer D.C., Davison K.S., Dian L., Hanley D.A., Harris S.T. et al. Vertebral fractures: clinical importance and management. Am. J. Med. 2016; 129(2): 221.e1-10. doi: 10.1016/j.amjmed.2015.09.020
36. Zhang H., Ma K., Li R.M., Li J.N., Gao S.F., Ma L.N. Association between testosterone levels and bone mineral density in females aged 40-60 years from NHANES 2011-2016. Sci. Rep. 2022; 12(1): 16426. https://dx.doi.org/10.1038/s41598-022-21008-7
37. Ghebre M.A., Hart D.J., Hakim A.J., Kato B.S., Thompson V., Arden N.K. et al. Association between DHEAS and bone loss in postmenopausal women: a 15-year longitudinal population-based study. Calcif. Tissue Int. 2011; 89(4): 295-302. https://dx.doi.org/10.1007/s00223-011-9518-9
38. Pöllänen E., Sipilä S., Alen M., Ronkainen P.H., Ankarberg-Lindgren C., Puolakka J. et al. Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women. Aging Cell. 2011; 10(4): 650-60. https://dx.doi.org/10.1111/j.1474-9726.2011.00701.x
39. Taylor S., Islam R.M., Bell R.J., Hemachandra C., Davis S.R. Endogenous testosterone concentrations and muscle mass, strength and performance in women, a systematic review of observational studies. Clin. Endocrinol. (Oxf.). 2023; 98(4): 587-602. https://dx.doi.org/10.1111/cen.14874
40. Wang Y., Islam R.M., Hussain S.M., McNeil J.J., Davis S.R. Associations between blood concentrations of sex hormones and physical function in community-dwelling older women: a prospective cohort study. J. Gerontol. A Biol. Sci. Med. Sci. 2024; 79(4): glad287. https://dx.doi.org/10.1093/gerona/glad287
41. Osmancevic A., Allison M., Miljkovic I., Vella C.A., Ouyang P., Trimpou P. et al. Exploring the relationships between sex hormones and abdominal muscle area and radiodensity in postmenopausal women: Insights from the multi-ethnic study of atherosclerosis. Maturitas. 2025; 194: 108197. https://dx.doi.org/10.1016/j.maturitas.2025.108197
42. Greendale G.A., Han W., Huang M.H., Upchurch D.M., Karvonen-Gutierrez C., Avis N.E. et al. Longitudinal assessment of physical activity and cognitive outcomes among women at midlife. JAMA Netw. Open. 2021; 4(3): e213227. https://dx.doi.org/10.1001/jamanetworkopen.2021.3227
43. Gilsanz P., Lee C., Corrada M.M., Kawas C.H., Quesenberry C.P. Jr., Whitmer R.A. Reproductive period and risk of dementia in a diverse cohort of health care members. Neurology. 2019; 92(17): e2005-e2014. https://dx.doi.org/10.1212/WNL.0000000000007326
44. Alzheimer’s Association Report. 2019 Alzheimer's disease facts and figures. Alzheimer’s & Dementia. 2019; 15: 321-87. https://dx.doi.org/10.1016/j.jalz.2019.01.010
45. Caldwell J.Z.K., Berg J.L., Cummings J.L., Banks S.J. Moderating effects of sex on the impact of diagnosis and amyloid positivity on verbal memory and hippocampal volume. Alzheimer’s Res. Ther. 2017; 9: 72. https://dx.doi.org/10.1186/s13195-017-0300-8
46. Hogervorst E., Williams J., Budge M., Riedel W., Jolles J. The nature of the effect of female gonadal hormone replacement therapy on cognitive function in post-menopausal women: a meta-analysis. Neuroscience. 2000; 101(3): 485-512. https://dx.doi.org/10.1016/S0306-4522(00)00410-3
47. Russell J.K., Jones C.K., Newhouse P.A. The role of estrogen in brain and cognitive aging. Neurotherapeutics. 2019; 16(3): 649-65. https://dx.doi.org/10.1007/s13311-019-00766-9
48. Rapp S.R., Espeland M.A., Shumaker S.A., Henderson V.W., Brunner R.L., Manson J.E. et al.; WHIMS Investigators. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial. JAMA. 2003; 289(20): 2663-72. https://dx.doi.org/10.1001/jama.289.20.2663
49. Shao H., Breitner J.C., Whitmer R.A., Wang J., Hayden K., Wengreen H. et al.; Cache County Investigators. Hormone therapy and Alzheimer disease dementia: new findings from the Cache County Study. Neurology. 2012; 79(18): 1846-52. https://dx.doi.org/10.1212/WNL.0b013e318271f823
50. Leranth C., Petnehazy O., MacLusky N.J. Gonadal hormones affect spine synaptic density in the CA1 hippocampal subfield of male rats. J. Neurosci. 2003; 23(5): 1588-92. https://dx.doi.org/10.1523/JNEUROSCI.23-05-01588.2003
51. Matsumoto A. Hormonally induced neuronal plasticity in the adult motoneurons. Brain Res. Bull. 1997; 44(4): 539-47. https://dx.doi.org/10.1016/s0361-9230(97)00240-2
52. Barreto G., Veiga S., Azcoitia I., Garcia-Segura L.M., Garcia-Ovejero D. Testosterone decreases reactive astroglia and reactive microglia after brain injury in male rats: role of its metabolites, oestradiol and dihydrotestosterone. Eur. J. Neurosci. 2007; 25(10): 3039-46. https://dx.doi.org/10.1111/j.1460-9568.2007.05563.x
53. Dratva M.A., Banks S.J., Panizzon M.S., Galasko D., Sundermann E.E.; Alzheimer’s Disease Neuroimaging Initiative. Low testosterone levels relate to poorer cognitive function in women in an APOE-ε4-dependant manner. Biol. Sex Differ. 2024; 15(1): 45. https://dx.doi.org/10.1186/s13293-024-00620-4
54. Sultana F., Davis S.R., Murray A.M., Woods R.L., McNeil J.J., Islam R.M. Sex hormones, SHBG and cognitive performance among older Australian women: an observational study. Climacteric. 2023; 26(2): 121-8. https://dx.doi.org/10.1080/13697137.2023.2166824
55. Sultana F., Davis S.R., Bell R.J., Taylor S., Islam R.M. Association between testosterone and cognitive performance in postmenopausal women: a systematic review of observational studies. Climacteric. 2023; 26(1): 5-14. https://dx.doi.org/10.1080/13697137.2022.2139600
56. Schindler A.E. Progestational effects of dydrogesterone in vitro, in vivo and on the human endometrium. Maturitas. 2009; 65 Suppl. 1: S3-11. https://dx.doi.org/10.1016/j.maturitas.2009.10.011
57. Schindler A.E., Campagnoli C., Druckmann R., Huber J., Pasqualini J.R., Schweppe K.W. et al. Classification and pharmacology of progestins. Maturitas. 2008; 61(1-2): 171-80. https://dx.doi.org/10.1016/j.maturitas.2008.11.013
58. Bianchi V.E., Bresciani E., Meanti R., Rizzi L., Omeljaniuk R.J., Torsello A. The role of androgens in women's health and wellbeing. Pharmacol. Res. 2021; 171: 105758. https://dx.doi.org/10.1016/j.phrs.2021.105758
59. Armeni E., Lambrinoudaki I. Menopause, androgens, and cardiovascular ageing: a narrative review. Ther. Adv. Endocrinol. Metab. 2022; 13: 20420188221129946. https://dx.doi.org/10.1177/20420188221129946
60. Дубровина С.О. Особенности консультирования пациенток старше 45 лет. Акушерство и гинекология. 2024; 4: 39-50.
61. Rizzo M.R., Leo S., De Franciscis P., Colacurci N., Paolisso G. Short-term effects of low-dose estrogen/drospirenone vs low-dose estrogen/dydrogesterone on glycemic fluctuations in postmenopausal women with metabolic syndrome. Age (Dordr.). 2014; 36(1): 265-74. https://dx.doi.org/10.1007/s11357-013-9554-7

Поступила 18.06.2025

Принята в печать 25.06.2025